Analysts predict Tarsus Pharmaceuticals' growth to outpace the industry with a 5x annualised growth by 2024. The upgraded price target indicates an expected increase in the business's intrinsic value.
$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks. Here are some top stocks in the sector climbing on drug trial and earnings news: $Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap. $Ligand Pharmaceuticals (LGND.US)$gained 23%...
Insider transactions at Tarsus Pharmaceuticals over the past year are not encouraging. Despite insiders owning shares, the net investment doesn't inspire much confidence.
Kenny Tey :
Despite FDA approval, price drop. That’s the good reason to buy. Sold all my IREN ... 80% loaded in TARSUS already . Let’s see next week ...
QUICK SCALP 23 $TARS — STOCK & OPTION PLAY ALERT ON: $23.02 ON THE WATCH: $23.18 🥇 SIGNED OF MORE UPTREND: $23.28 NEED IT TO BREAK OVER: $23.36 key indicator for MORE uptrend $23.44 confirmation uptrend - $23.54 OK I SEE YOU - $23.71 mini breakout - $23.87 Prepare for a bigger breakout: $23.97.$Tarsus Pharmaceuticals(TARS.US)$
Gainers: •$Innoviz Technologies(INVZ.US)$+18.7% (selected by "large automotive group manufacturer" to become its direct LiDAR supplier across multiple brands) •$希尔托普控股(HTH.US)$+15.7% (commenced a modified "Dutch auction" tender offer to purchase for cash up to $400 mln of its common stock at a price per share not less than $28,00 and not greater than $32.00 less any applicable withholding taxes and without interest usin...
18
3
2
举报
Dino 64 :
Nio is a pre market mover alright.....DOWN.
Tarsus Pharmaceuticals股票讨论区
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
$Leap Therapeutics(LPTX.US)$ Phase 2
$Vera Therapeutics(VERA.US)$ Phase 2b
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$Akero Therapeutics(AKRO.US)$ Phase 2b
$Spruce Biosciences(SPRB.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$阿里拉姆制药(ALNY.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Annexon(ANNX.US)$ Phase 2a
$Roivant Sciences(ROIV.US)$...
How to identify Marubozu Candle
Weekly & and daily Marubozu candle occured for TARSUS...
drop in price despite FDa approval
ALERT ON: $23.02
ON THE WATCH: $23.18
🥇 SIGNED OF MORE UPTREND: $23.28
NEED IT TO BREAK OVER: $23.36
key indicator for MORE uptrend $23.44
confirmation uptrend - $23.54
OK I SEE YOU - $23.71
mini breakout - $23.87
Prepare for a bigger breakout: $23.97. $Tarsus Pharmaceuticals(TARS.US)$
• $Innoviz Technologies(INVZ.US)$ +18.7% (selected by "large automotive group manufacturer" to become its direct LiDAR supplier across multiple brands)
• $希尔托普控股(HTH.US)$ +15.7% (commenced a modified "Dutch auction" tender offer to purchase for cash up to $400 mln of its common stock at a price per share not less than $28,00 and not greater than $32.00 less any applicable withholding taxes and without interest usin...
暂无评论